Recent biotech IPOs get fewer new investors than it appears, says report
March 18, 2016 at 07:22 AM EDT
The biotechs that have gone public so far this year, most of which have been in Massachusetts, have attracted far fewer new investors than it might seem, leading IPO analysts at Renaissance Capital to go so far as to call them “quasi-IPOs...